Europe: Sanofi’s dengue vaccine gets approved
by Press Release from Outbreak News Today on (#45BCQ)
The European Commission has granted marketing authorization for Dengvaxia(R), Sanofi's dengue vaccine. The marketing authorization follows the October 18, 2018, recommendation by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) to approve use of the dengue vaccine in European endemic areas. Dengvaxia(R) will be available in Europe to prevent dengue disease ["]
The post Europe: Sanofi's dengue vaccine gets approved appeared first on Outbreak News Today.